COMMUNIQUÉS West-GlobeNewswire

Kensana Health Lands $120 million from GEM, Fuelling a Global Plant Based Medicine Revolution
19/09/2025
The company expects to list on NASDAQ in Q2 2026 NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Kensana Health Inc. (“Kensana”) today announced it has entered into a share subscription facility of up to $120 million with [...]
Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million Americans
19/09/2025
WARREN, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today expressed its gratitude to the U.S. Department of Health and Human Services (HHS), Secretary [...]
Hydreight Announces Annual General Meeting Results
19/09/2025
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“ Hydreight ” or the “ Company ”), is pleased to announce that at the 2025 Annual General [...]
TREMFYA (guselkumab) receives positive CHMP opinion for subcutaneous induction regimen in ulcerative colitis, a first for an IL-23 inhibitor
19/09/2025
Recommendation based on the findings from the Phase 3 ASTRO study in ulcerative colitis. 1 , 2 , 3 Guselkumab has the potential to become the first IL-23 inhibitor to offer both subcutaneous and intravenous induction [...]
Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups
19/09/2025
WALTHAM, Mass., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative therapies for age-related degenerative diseases, today [...]
Acarpia Farmaceutici et EarlyHealth Group élargissent leur partenariat afin d’améliorer l’accès à CARICOM et au Mexique
19/09/2025
MILAN, 19 sept. 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., un fabricant pharmaceutique italien, et EarlyHealth Group, un prestataire mondial de services pharmaceutiques, ont annoncé l’élargissement de leur [...]
Jasper Therapeutics Announces Pricing of $30 Million Public Offering of Common Stock, Pre-Funded Warrants and Common Warrants
19/09/2025
REDWOOD CITY, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical-stage biotechnology company focused on development of briquilimab, a novel antibody therapy [...]
Kraig Biocraft Laboratories Expands Spider Silk Manufacturing with Pursuit of Additional Rearing Center
19/09/2025
ANN ARBOR, Mich., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it is actively pursuing [...]
SAB BIO Highlights Data in Multiple Presentations at EASD
19/09/2025
-As SAB initiates its Phase 2b SAFEGUARD study for SAB-142 in new-onset Stage 3 autoimmune T1D patients, EASD provided an opportunity to connect with many T1D thought leaders that will participate in the study- -Data in [...]
Johnson & Johnson receives positive CHMP opinion of nipocalimab to treat a broad population of antibody-positive patients living with generalised myasthenia gravis (gMG)
19/09/2025
Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive CHMP [...]
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
19/09/2025
REYKJAVIK, ICELAND (September 19, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its [...]
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
19/09/2025
REYKJAVIK, Iceland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced [...]
Bylvay® (odévixibat) approuvé au Japon pour le traitement d’une maladie rare du foie (CIFP)
19/09/2025
Bylvay ® est le premier inhibiteur du transport iléal des acides biliaires administré une fois par jour à être approuvé comme traitement du prurit associé à la cholestase intra-hépatique familiale progressive (CIFP) au [...]
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC
19/09/2025
Bylvay ® is the first once-daily ileal bile acid transport inhibitor to be approved as a treatment for pruritus associated with progressive familial intrahepatic cholestasis (PFIC) in Japan, offering a non-surgical [...]
Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum
19/09/2025
– Approval triggers $10 million cash milestone payment to Verrica – – YCANTH ® approval in Japan addresses significant unmet need of patients with molluscum – – Verrica maintains ownership of global rights to YCANTH for [...]
Vaxart Announces Withdrawal of Reverse Stock Split Proposal
19/09/2025
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based [...]
Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025
19/09/2025
DALLAS, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
19/09/2025
neffy 1 mg and 2 mg doses approved by Japanese regulators neffy offers a new delivery method for epinephrine in Japan for adults and children ( > 15 kg) living with severe allergic reactions Alfresa Holdings, which [...]
Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Parma in Ohio, Expanding its Statewide Retail Footprint
19/09/2025
Sixth Beyond Hello Location in Ohio and 41 st Retail Location Nationwide New Dispensary Opens September 19 th in Parma, Just South of Cleveland Grand Opening Celebration with Exclusive Promotions September 19 – October [...]

Pages